We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sekisui Diagnostics

For 40 years SEKISUI Diagnostics has been committed to providing innovative medical diagnostics to physicians and lab... read more Featured Products: More products

Download Mobile App




Sekisui Diagnostics Displays POC Rapid Diagnostics and Clinical Chemistry Reagents at AACC 2021

By LabMedica International staff writers
Posted on 28 Sep 2021

SEKISUI Diagnostics (Burlington, MA, USA) displayed its point-of-care rapid diagnostics and clinical chemistry reagents at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo. More...

This year’s 2021 AACC was held in partnership with the Canadian Society of Clinical Chemists (CSCC) at the Georgia World Congress Center in Atlanta, September 26-30. SEKISUI Diagnostics delivers differentiated products, instrument systems, and services that support the improvement of patient care worldwide. The company is a recognized leader in the development, manufacture, and supply of innovative clinical chemistry reagents and systems that enhance the clinical chemistry laboratory function. Over 1.7 billion tests are performed each year using the company’s products. With a broad line of >65 reagents including cardiovascular, diabetes, renal, liver, therapeutic drug, and specialty assays, SEKISUI is well-poised to meet individual needs.

At AACC 2021, SEKISUI displayed its OSOM rapid diagnostics that offers a variety of family and women’s health products, and services. These diagnostic tests allow healthcare professionals to cost effectively diagnose at the point-of-care in one visit, thus reducing labor and follow-up time while increasing patient satisfaction. The company also demonstrated its Acucy System that provides clinicians with flexibility in workflow and accurate, standardized results for improved patient care.

Also on display was SEKISUI’s FastPack IP System which is a fully automated quantitative immunoassay analyzer designed for use in any size physician office laboratory and provides results in 12 minutes or less with the push of a button. Offering real-time testing with a simple three-step process, the system enables healthcare professionals to diagnose, monitor, and adjust therapy in one patient visit.

Related Links:
SEKISUI Diagnostics 


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.